SARS-CoV-2 Secondary Attack Rates in Vaccinated and Unvaccinated Household Contacts during Replacement of Delta with Omicron Variant, Spain
Israel López-Muñoz, Ariadna Torrella, Olga Pérez-Quílez, Amaia Castillo-Zuza, Elisa Martró, Antoni E. Bordoy, Verónica Saludes, Ignacio Blanco, Laura Soldevila, Oriol Estrada, Lluís Valerio, Sílvia Roure, and Xavier Vallès
Author affiliations: North Metropolitan International Health Program, Catalan Institute of Health (PROSICS), Badalona, Spain (I. López-Muñoz, A. Torrella, O. Pérez-Quílez, A. Castillo-Zuza, L. Soldevila, L. Valerio, S. Roure, X. Vallès); Hospital Universitari Germans Trias i Pujol, Badalona (E. Martró, A.E. Bordoy, V. Saludes, I. Blanco, L. Soldevila, S. Roure); Center for Biomedical Research in Epidemiology and Public Health (CIBEREPS), Instituto de Salud Carlos III, Madrid, Spain (E. Martró, A.E. Bordoy, V. Saludes); Institut d’Investigació en Ciències de la Salut Germans Trias i Pujol, Badalona (E. Martró, A.E. Bordoy, V. Saludes, I. Blanco, O. Estrada, X. Vallès); Fundació Lluita contra la Sida i les Malalties Transmissibles, Badalona (L. Soldevila, S. Roure, X. Vallès)
Main Article
Figure 1
Figure 1. Dominance of infection with SARS-CoV-2 Delta and Omicron variants in a study of secondary attack rates in vaccinated and unvaccinated household contacts, Spain. The study population was located in the northern part of the greater metropolitan area of Barcelona, Spain. Genotyping of 1,554 samples from patients with SARS-CoV-2 infections was conducted during November 23, 2020–February 8, 2021 to identify the dominant variant infecting the population. The cutoff date between the Delta and Omicron predominance periods was December 21, 2021.
Main Article
Page created: August 11, 2022
Page updated: September 20, 2022
Page reviewed: September 20, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.